Abacavir hypersensitivity reaction is a clinical syndrome characterized by fever, rash, and other systemic complaints within 6 weeks of abacavir initiation. These symptoms remit when the drug is ...

Screening prospectively for HLA-B*5701 — and avoiding abacavir use in those who test positive — reduces the incidence of hypersensitivity reaction to this NRTI. Abacavir is an attractive drug ...